InvestorsHub Logo

Sojourner55

12/15/17 11:07 AM

#149597 RE: TC_Trader #149594

Thanks TC. Good to see the Dr Gottlieb nudging the FDA bureaucracy in the right direction. Now only for the SEC to shut the boiler room guys that have been attacking the small innovative companies and depleting them of capital.

Anyone got blocked by AF on Twitter? Chris woke up this morning to find out he was blocked. AF was snooping in my account last night and blocked me shortly after. What has he got to hide?

marzan

12/15/17 11:10 AM

#149598 RE: TC_Trader #149594

Thanks TC! FDA keeps telling they are working on a phenomenal change in the way they approve drugs and therapies. With the success they saw in CIs in the ImmunoOncology area, they are ready to make swift changes in their approval process. Swift I mean Fast approvals! who is standing next? ofcourse DcVaxL. As a govt agency, FDA is releasing guidance on a daily basis which I never saw in the past on immunotherapy cell therapy individualized therapy what not - it is ready to clear dendritic cell therapy on solid cancers, imo. Do you think we get news before xmas?

sbnyc

12/16/17 1:30 AM

#149651 RE: TC_Trader #149594

Scott Gottlieb said, “We also recently authorized three, novel next generation sequencing-based devices for the detection of multiple cancer markers with the run of a single test – enabling the development of evidence to drive more individualized care management decisions.”
Does anyone know what he is referring to?
I’ll do some searching myself. Thanks.
sbnyc